$MYSZ
My Size, Inc.

2015 Q3 Form 10-Q Financial Statement

#000114420415050833 Filed on August 20, 2015

View on sec.gov

Income Statement

Concept 2015 Q3 2015 Q2 2014 Q2
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $364.0K $458.0K $97.00K
YoY Change 208.47% 372.16% 7.78%
% of Gross Profit
Research & Development $112.0K $69.00K $0.00
YoY Change -12.5%
% of Gross Profit
Depreciation & Amortization $0.00 $0.00 $0.00
YoY Change
% of Gross Profit
Operating Expenses $476.0K $527.0K $97.00K
YoY Change 93.5% 443.3% 7.78%
Operating Profit -$476.0K -$527.0K -$97.00K
YoY Change 93.5% 443.3%
Interest Expense -$1.150M -$370.0K $10.00K
YoY Change 11400.0% -3800.0% -200.0%
% of Operating Profit
Other Income/Expense, Net $0.00 $0.00 -$2.000K
YoY Change -100.0%
Pretax Income -$1.630M -$900.0K -$60.00K
YoY Change 1937.5% 1400.0% -40.0%
Income Tax
% Of Pretax Income
Net Earnings -$1.614M -$893.0K -$88.00K
YoY Change 462.37% 914.77% -12.0%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$2.67 -$1.46 -$0.13
COMMON SHARES
Basic Shares Outstanding 15.31M shares 15.31M shares 12.52M shares
Diluted Shares Outstanding 15.31M shares 12.52M shares

Balance Sheet

Concept 2015 Q3 2015 Q2 2014 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.895M $550.0K $0.00
YoY Change 198.45%
Cash & Equivalents $1.629M $545.0K $4.000K
Short-Term Investments $1.266M
Other Short-Term Assets $1.030M
YoY Change
Inventory
Prepaid Expenses
Receivables $120.0K $70.00K $40.00K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $4.048M $620.0K $50.00K
YoY Change 296.86% 1140.0% 150.0%
LONG-TERM ASSETS
Property, Plant & Equipment $39.00K $36.00K
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $39.00K $36.00K $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $4.048M $620.0K $50.00K
Total Long-Term Assets $39.00K $36.00K $0.00
Total Assets $4.087M $656.0K $50.00K
YoY Change 300.69% 1212.0% 150.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $139.0K $180.0K $160.0K
YoY Change -0.71% 12.5% -60.98%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $3.050M $420.0K $140.0K
YoY Change 4257.14% 200.0% 133.33%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $6.713M $1.253M $300.0K
YoY Change 2585.2% 317.67% -57.75%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $6.713M $1.253M $300.0K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $6.720M $1.260M $300.0K
YoY Change 2588.0% 320.0% -57.75%
SHAREHOLDERS EQUITY
Retained Earnings -$6.744M -$5.130M
YoY Change
Common Stock $15.00K $15.00K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$2.626M -$597.0K -$243.0K
YoY Change
Total Liabilities & Shareholders Equity $4.087M $656.0K $50.00K
YoY Change 300.69% 1212.0% 150.0%

Cashflow Statement

Concept 2015 Q3 2015 Q2 2014 Q2
OPERATING ACTIVITIES
Net Income -$1.614M -$893.0K -$88.00K
YoY Change 462.37% 914.77% -12.0%
Depreciation, Depletion And Amortization $0.00 $0.00 $0.00
YoY Change
Cash From Operating Activities -$290.0K -$400.0K -$60.00K
YoY Change 11.54% 566.67% -700.0%
INVESTING ACTIVITIES
Capital Expenditures $10.00K $0.00 $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$10.00K $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.380M 510.0K 60.00K
YoY Change 7.81% 750.0%
NET CHANGE
Cash From Operating Activities -290.0K -400.0K -60.00K
Cash From Investing Activities -10.00K 0.000 0.000
Cash From Financing Activities 1.380M 510.0K 60.00K
Net Change In Cash 1.080M 110.0K 0.000
YoY Change 5.88% -100.0%
FREE CASH FLOW
Cash From Operating Activities -$290.0K -$400.0K -$60.00K
Capital Expenditures $10.00K $0.00 $0.00
Free Cash Flow -$300.0K -$400.0K -$60.00K
YoY Change 15.38% 566.67% -700.0%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2015Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2015Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2015Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15313793 shares
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15313793 shares
CY2015Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15313793 shares
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15313793 shares
CY2015Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
545000 USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
645000 USD
us-gaap Use Of Estimates
UseOfEstimates
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0in; MARGIN: 0pt 0px 0pt 56.7pt; FONT: 10pt Times New Roman, Times, Serif" align="justify"></div> <table style="MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt" cellspacing="0" cellpadding="0" width="100%"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 56.7pt"> <div style="CLEAR:both;CLEAR: both"></div> </td> <td style="WIDTH: 28.35pt"> <div style="CLEAR:both;CLEAR: both">a.</div> </td> <td style="TEXT-ALIGN: justify"> <div style="CLEAR:both;CLEAR: both">Use of estimates:</div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0in; MARGIN: 0pt 0px 0pt 85.05pt; FONT: 10pt Times New Roman, Times, Serif" align="justify">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
us-gaap Net Income Loss
NetIncomeLoss
-1257000 USD
us-gaap Net Income Loss
NetIncomeLoss
69000 USD
dei Document Type
DocumentType
10-Q
dei Amendment Flag
AmendmentFlag
false
dei Document Period End Date
DocumentPeriodEndDate
2015-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Registrant Name
EntityRegistrantName
My Size, Inc.
dei Entity Central Index Key
EntityCentralIndexKey
0001211805
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
dei Trading Symbol
TradingSymbol
MYSZ
CY2015Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
15313793 shares
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 85.05pt; FONT: 10pt Times New Roman, Times, Serif" align="justify"></div> <table style="MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt" cellspacing="0" cellpadding="0" width="100%"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 56.7pt"> <div style="CLEAR:both;CLEAR: both"></div> </td> <td style="WIDTH: 28.35pt"> <div style="CLEAR:both;CLEAR: both">n.</div> </td> <td style="TEXT-ALIGN: justify"> <div style="CLEAR:both;CLEAR: both">Concentrations of credit risk:</div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 85.05pt; FONT: 10pt Times New Roman, Times, Serif" align="justify">Financial instruments that potentially subject the Company and its subsidiaries to concentrations of credit risk consist principally of cash and cash equivalents.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 85.05pt; FONT: 10pt Times New Roman, Times, Serif" align="justify">Cash and cash equivalents are invested in major banks in Israel. Such deposits in Israel may be in excess of insured limits and are not insured in other jurisdictions. Management believes that the financial institutions that hold the Company<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">&#8217;</font>s investments are financially sound and, accordingly, minimal credit risk exists with respect to these investments.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: -56.7pt; MARGIN: 0pt 0px 0pt 56.7pt; FONT: bold 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 85.05pt; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Company and its subsidiaries have no off-balance-sheet concentration of credit risk such as foreign exchange contracts, option contracts or other foreign hedging arrangements.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2015Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
75000 USD
CY2014Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
43000 USD
us-gaap Depreciation
Depreciation
3000 USD
CY2015Q2 us-gaap Assets Current
AssetsCurrent
620000 USD
CY2014Q4 us-gaap Assets Current
AssetsCurrent
688000 USD
us-gaap Interest Expense Debt
InterestExpenseDebt
399000 USD
us-gaap Interest Expense Debt
InterestExpenseDebt
-58000 USD
mysz Purchase Of Property And Equipment
PurchaseOfPropertyAndEquipment
0 USD
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 USD
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
57000 USD
us-gaap Proceeds From Issuance Of Other Long Term Debt
ProceedsFromIssuanceOfOtherLongTermDebt
525000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
188000 USD
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
0 USD
us-gaap Share Based Compensation
ShareBasedCompensation
200000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
0 USD
us-gaap Extinguishment Of Debt Amount
ExtinguishmentOfDebtAmount
0 USD
us-gaap Extinguishment Of Debt Amount
ExtinguishmentOfDebtAmount
-197000 USD
us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
-11000 USD
us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
-65000 USD
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-39000 USD
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
19000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-597000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-270000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
30000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
0 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-14000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
0 USD
mysz Purchase Of Property And Equipment
PurchaseOfPropertyAndEquipment
14000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
525000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
245000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
-14000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
24000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-100000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-1000 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5000 USD
CY2014Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4000 USD
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
0 USD
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
96000 USD
mysz Waiver Of Shareholder Debt
WaiverOfShareholderDebt
0 USD
mysz Waiver Of Shareholder Debt
WaiverOfShareholderDebt
253000 USD
CY2015Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
36000 USD
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
24000 USD
CY2015Q2 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
0 USD
CY2014Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
67000 USD
CY2015Q2 us-gaap Assets
Assets
656000 USD
CY2014Q4 us-gaap Assets
Assets
779000 USD
CY2015Q2 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
492000 USD
CY2014Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
72000 USD
CY2015Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
180000 USD
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
186000 USD
CY2015Q2 us-gaap Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
36000 USD
CY2014Q4 us-gaap Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
6000 USD
CY2015Q2 us-gaap Deferred Compensation Share Based Arrangements Liability Current
DeferredCompensationShareBasedArrangementsLiabilityCurrent
457000 USD
CY2014Q4 us-gaap Deferred Compensation Share Based Arrangements Liability Current
DeferredCompensationShareBasedArrangementsLiabilityCurrent
0 USD
CY2015Q2 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
88000 USD
CY2014Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
37000 USD
CY2015Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1253000 USD
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
301000 USD
CY2015Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2014Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2015Q2 us-gaap Common Stock Value
CommonStockValue
15000 USD
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
15000 USD
CY2015Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
4655000 USD
CY2014Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
4455000 USD
CY2015Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-5130000 USD
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3873000 USD
CY2015Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-137000 USD
CY2014Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-119000 USD
CY2015Q2 us-gaap Stockholders Equity
StockholdersEquity
-597000 USD
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
478000 USD
CY2015Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
656000 USD
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
779000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
105000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
0 USD
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.08
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.01
CY2015Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
69000 USD
CY2014Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
0 USD
us-gaap Marketing Expense
MarketingExpense
382000 USD
us-gaap Marketing Expense
MarketingExpense
0 USD
CY2015Q2 us-gaap Marketing Expense
MarketingExpense
212000 USD
CY2014Q2 us-gaap Marketing Expense
MarketingExpense
0 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
382000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
186000 USD
CY2015Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
246000 USD
CY2014Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
97000 USD
us-gaap Operating Expenses
OperatingExpenses
869000 USD
us-gaap Operating Expenses
OperatingExpenses
186000 USD
CY2015Q2 us-gaap Operating Expenses
OperatingExpenses
527000 USD
CY2014Q2 us-gaap Operating Expenses
OperatingExpenses
97000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-869000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-186000 USD
CY2015Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-527000 USD
CY2014Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-97000 USD
us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
-388000 USD
us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
46000 USD
CY2015Q2 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
-366000 USD
CY2014Q2 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
11000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
209000 USD
CY2015Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 USD
CY2014Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2000 USD
CY2015Q2 us-gaap Net Income Loss
NetIncomeLoss
-893000 USD
CY2014Q2 us-gaap Net Income Loss
NetIncomeLoss
-88000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
-18000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
40000 USD
CY2015Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
-11000 USD
CY2014Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
26000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1275000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
109000 USD
CY2015Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-904000 USD
CY2014Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-62000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1257000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
69000 USD
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-1257000 USD
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
34000 USD
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9919445 shares
CY2015Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.06
CY2014Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.01
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10815611 shares
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.08
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.00
CY2015Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.06
CY2014Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.01
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15313798 shares
CY2015Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15313798 shares
CY2014Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12521918 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15313798 shares
CY2015Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15313798 shares
CY2014Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12521918 shares
CY2014Q1 mysz Percentage Of Operating Profit
PercentageOfOperatingProfit
0.18 pure
CY2014Q1 mysz Purchasing Venture Agreement Terms
PurchasingVentureAgreementTerms
As part of the agreement, the Seller received an option to buy back the Venture, for consideration which will reflect the market fair value at that time, on the occurrence of the following events: a) If a motion has been filed to liquidate the Company; b) If 7 years after signing the agreement, the Companys total accumulated revenues, direct or indirect, from the Venture or the commercialization of the patent will be lower than 3.6 million NIS.
CY2014 us-gaap Net Income Loss
NetIncomeLoss
468000 USD
CY2014 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
733000 USD
us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Percent
DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
0.0833 pure
mysz Amount Of Dilutive Securities Warrants To Purchase Common Stock
AmountOfDilutiveSecuritiesWarrantsToPurchaseCommonStock
-39000 USD
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
24146 shares
us-gaap Amount Of Dilutive Securities Stock Options And Restrictive Stock Units
AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits
0 USD
mysz Incremental Common Shares Attributable To Dilutive Effect Of Options
IncrementalCommonSharesAttributableToDilutiveEffectOfOptions
45990 shares
us-gaap Dilutive Securities Effect On Basic Earnings Per Share Other
DilutiveSecuritiesEffectOnBasicEarningsPerShareOther
4000 USD
us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
826030 shares
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
200000 USD
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
-889000 USD
CY2014Q2 us-gaap Stockholders Equity
StockholdersEquity
-243000 USD
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
188000 USD
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
96000 USD
mysz Adjustment To Additional Paid In Capital Waiver Of Related Parties Debt
AdjustmentToAdditionalPaidInCapitalWaiverOfRelatedPartiesDebt
253000 USD
mysz Stock Issuance Stock
StockIssuanceStock
26000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
96000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
0 USD
CY2015Q1 mysz Non Interest Bearing Period
NonInterestBearingPeriod
8 months
mysz Convertible Debt And Warrants
ConvertibleDebtAndWarrants
4025000 USD

Files In Submission

Name View Source Status
0001144204-15-050833-index-headers.html Edgar Link pending
0001144204-15-050833-index.html Edgar Link pending
0001144204-15-050833.txt Edgar Link pending
0001144204-15-050833-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
mysz-20150630.xml Edgar Link completed
mysz-20150630.xsd Edgar Link pending
mysz-20150630_cal.xml Edgar Link unprocessable
mysz-20150630_def.xml Edgar Link unprocessable
mysz-20150630_lab.xml Edgar Link unprocessable
mysz-20150630_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v418572_10q.htm Edgar Link pending
v418572_ex31-1.htm Edgar Link pending
v418572_ex31-2.htm Edgar Link pending
v418572_ex32-1.htm Edgar Link pending
v418572_ex32-2.htm Edgar Link pending